Update on CTN-0082

The CTN-0082 primary outcomes article was recently featured in the NIDA HIV Research Program email newsletter:

HIV News from NIDA

What predicts willingness to take PrEP among people who use opioids? 
A cross-sectional survey developed by NIDA’s Clinical Trials Network was given to 308 HIV-negative people who use opioids (PWUO) across eight Southern cities with high HIV incidence. Half had heard of PrEP, but only 4% had ever taken it. Investigators found that willingness to take daily oral PrEP and willingness to take long-acting injectable (LAI) PrEP were moderately high (69.16% and 62.02%, respectively). Educational attainment and having engaged in condomless vaginal sex predicted willingness to take oral PrEP, whereas only educational attainment predicted willingness to take LAI PrEP. The authors suggest these findings could inform more targeted public health messaging.

The CTN-0082 outcomes article was authored by Mary A. Hatch of the Pacific Northwest Node and colleagues and is titled “PrEP for people who use opioids: A NIDA Clinical Trials Network survey study in Southern U.S. cities where HIV incidence is high.” Drug Alcohol Depend 2024;257:111133. Find it in the CTN Dissemination Library.

Subscribe to the NIDA HIV Research Program newsletter here!